| NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias L Scott Jr, AC Fender, A Saljic, L Li, X Chen, X Wang, D Linz, J Lang, ... Cardiovascular research 117 (7), 1746-1759, 2021 | 95 | 2021 |
| Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications M Gawałko, TA Agbaedeng, A Saljic, DN Müller, N Wilck, R Schnabel, ... Cardiovascular Research 118 (11), 2415-2427, 2022 | 77 | 2022 |
| Emerging antiarrhythmic drugs for atrial fibrillation A Saljic, J Heijman, D Dobrev International Journal of Molecular Sciences 23 (8), 4096, 2022 | 33 | 2022 |
| Enhanced Ca2+-Dependent SK-Channel Gating and Membrane Trafficking in Human Atrial Fibrillation J Heijman, X Zhou, S Morotti, CE Molina, IH Abu-Taha, M Tekook, ... Circulation research 132 (9), e116-e133, 2023 | 25 | 2023 |
| Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance M Gawałko, A Saljic, N Li, I Abu-Taha, T Jespersen, D Linz, S Nattel, ... Cardiovascular Research 119 (3), 614-630, 2023 | 24 | 2023 |
| Inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut: a new antihypertensive concept B Linz, A Saljic, M Hohl, M Gawałko, T Jespersen, P Sanders, M Böhm, ... IJC Heart & Vasculature 29, 100591, 2020 | 20 | 2020 |
| Anti‐arrhythmic investigations in large animal models of atrial fibrillation A Saljic, T Jespersen, R Buhl British journal of pharmacology 179 (5), 838-858, 2022 | 17 | 2022 |
| Pharmacological rescue of mutated Kv3. 1 ion-channel linked to progressive myoclonus epilepsies AS Munch, A Saljic, K Boddum, M Grunnet, C Hougaard, T Jespersen European journal of pharmacology 833, 255-262, 2018 | 15 | 2018 |
| First catheter‐based high‐density endocardial 3D electroanatomical mapping of the right atrium in standing horses E Hesselkilde, D Linz, A Saljic, H Carstensen, R Kutieleh, T Jespersen, ... Equine veterinary journal 53 (1), 186-193, 2021 | 14 | 2021 |
| TGF-β1–induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation? A Saljic, E Grandi, D Dobrev The Journal of Clinical Investigation 132 (13), 2022 | 12 | 2022 |
| Recent advances in antiarrhythmic drug therapy A Saljic, J Heijman, D Dobrev Drugs 83 (13), 1147-1160, 2023 | 11 | 2023 |
| Sleep apnea and atrial fibrillation: challenges in clinical and translational research B Linz, J Norup Hertel, J Hendriks, A Saljic, D Dobrev, M Baumert, ... Expert review of cardiovascular therapy 20 (2), 101-109, 2022 | 11 | 2022 |
| Arrhythmogenic mechanisms of acute obstructive respiratory events in a porcine model of drug-induced long QT B Linz, SM Sattler, M Flethøj, MEH Hansen, EM Hesselkilde, A Saljic, ... Heart Rhythm 18 (8), 1384-1391, 2021 | 11 | 2021 |
| Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation J Song, JA Navarro-Garcia, J Wu, A Saljic, I Abu-Taha, L Li, SK Lahiri, ... The Journal of Clinical Investigation 133 (19), 2023 | 10 | 2023 |
| Impact of arrhythmogenic calmodulin variants on small conductance Ca2+‐activated K+ (SK3) channels A Saljic, KM Muthukumarasamy, JM la Cour, K Boddum, M Grunnet, ... Physiological Reports 7 (19), e14210, 2019 | 9 | 2019 |
| Regulation of Kv1. 4 potassium channels by PKC and AMPK kinases MN Andersen, L Skibsbye, A Saljic, MZ Larsen, HB Rasmussen, ... Channels 12 (1), 34-44, 2018 | 9 | 2018 |
| Increased fibroblast accumulation in the equine heart following persistent atrial fibrillation A Saljic, MF Fenner, J Winters, M Flethøj, CE Eggertsen, H Carstensen, ... IJC Heart & Vasculature 35, 100842, 2021 | 8 | 2021 |
| In vivo knockdown of SK3 channels using antisense oligonucleotides protects against atrial fibrillation in rats A Saljic, L Soattin, DS Trachsel, K Boddum, T Jespersen Journal of molecular and cellular cardiology 147, 18-26, 2020 | 8 | 2020 |
| Researchers in cardiology–Why and how to get on Twitter? DB Fyenbo, TC Frederiksen, D Linz, T Jespersen, D Dobrev, G Gislason, ... IJC Heart & Vasculature 40, 101010, 2022 | 7 | 2022 |
| Pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut reduces atrial fibrillation susceptibility in obese spontaneously … B Linz, M Hohl, R Mishima, A Saljic, DH Lau, T Jespersen, U Schotten, ... IJC Heart & Vasculature 28, 100534, 2020 | 7 | 2020 |
